Product Information
IPRATROPIUM BR 0.02% SOLN is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1128 per ML under NDC 65862090560. Its NADAC has been published 368 times since Aug 8, 2018.
FDA first approved this application on Oct 27, 2016. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2.5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862090560
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
8/20/2025
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206543FDA Approved
10/27/2016
TE Code
AN
On Market Since
10/27/2016
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM BR 0.02% SOLN has been published 368 times since Aug 8, 2018, and over the history we have for it it has risen 125.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1128 per ML |
|---|---|
| All-time high | $0.1142 (Aug 13, 2025) |
| All-time low | $0.0440 (Nov 21, 2018) |
| Median price | $0.0589 |
| Average price | $0.0676 |
| Largest weekly change | +21.5% (Mar 20, 2024) |
| Weeks tracked | 368 |
| Tracking since | Aug 8, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+43.5%
5Y
+96.3%
All
+125.9%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM BR 0.02% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM BR 0.02% SOLN, manufactured by Aurobindo Pharma Limited, is $0.1128 per ML (NDC 65862090560), effective Aug 20, 2025.
How has the price of IPRATROPIUM BR 0.02% SOLN changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM BR 0.02% SOLN has risen 125.9%. It has been tracked across 368 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM BR 0.02% SOLN?
Since Aug 8, 2018, the NADAC for IPRATROPIUM BR 0.02% SOLN has ranged from a low of $0.0440 (Nov 21, 2018) to a high of $0.1142 (Aug 13, 2025), with a median of $0.0589 per ML.
Are there cheaper alternatives to IPRATROPIUM BR 0.02% SOLN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IPRATROPIUM BR 0.02% SOLN, is $0.0957 per ML — about 15% below IPRATROPIUM BR 0.02% SOLN.
Who manufactures IPRATROPIUM BR 0.02% SOLN?
IPRATROPIUM BR 0.02% SOLN (NDC 65862090560) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.